Annual report
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.4 pts less than Nifty Microcap 250 and 2.0 pts less than its Other Financial Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Arunjyoti Bio Ventures Ltd has submitted its 39th Annual Report for the financial year 2024-25 to BSE. The 39th Annual General Meeting is scheduled for September 10, 2025, at 11:00 a.m. via video conferencing. The company manufactures and trades packaged drinking water (TCW), Gluco+ and jelly products. Revenue grew strongly from Rs. 2043.15 lakhs in FY24 to Rs. 2788.41 lakhs in FY25, a rise of about 36%, but the company remained loss-making, with net loss after tax widening to Rs. 182.15 lakhs (from a loss of Rs. 34.89 lakhs in FY24). Statutory auditor M/s. V. Ravi & Co. resigned on August 3, 2025 citing pre-occupation, and M/s. PKF Sridhar & Santhanam LLP has been appointed to fill the casual vacancy and for a five-year term. The notice also seeks shareholder approval for re-appointment of three whole-time directors.
Positive revenue growth signals improving topline momentum, but widening losses and a change of statutory auditor before the AGM may concern shareholders about profitability discipline and audit continuity. Watch for the AGM voting outcomes and the new auditor's report.